278 related articles for article (PubMed ID: 18377785)
1. Pharmacotherapy for obesity.
Neff LM; Aronne LJ
Curr Atheroscler Rep; 2007 Dec; 9(6):454-62. PubMed ID: 18377785
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacotherapy for obesity: current drugs and those in advanced development.
Halford JC
Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253
[TBL] [Abstract][Full Text] [Related]
4. Obesity drug therapy.
Baretić M
Minerva Endocrinol; 2013 Sep; 38(3):245-54. PubMed ID: 24126545
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in obesity pharmacotherapy.
Mayer MA; Höcht C; Puyó A; Taira CA
Curr Clin Pharmacol; 2009 Jan; 4(1):53-61. PubMed ID: 19149502
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacotherapy in the treatment of obesity].
Hamann A
MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for obesity in menopausal women.
Samat A; Rahim A; Barnett A
Menopause Int; 2008 Jun; 14(2):57-62. PubMed ID: 18519266
[TBL] [Abstract][Full Text] [Related]
8. Drug treatments for obesity: orlistat, sibutramine, and rimonabant.
Padwal RS; Majumdar SR
Lancet; 2007 Jan; 369(9555):71-7. PubMed ID: 17208644
[TBL] [Abstract][Full Text] [Related]
9. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
Leung WY; Thomas GN; Chan JC; Tomlinson B
Clin Ther; 2003 Jan; 25(1):58-80. PubMed ID: 12637112
[TBL] [Abstract][Full Text] [Related]
10. Emerging concepts in the medical and surgical treatment of obesity.
Aylwin S; Al-Zaman Y
Front Horm Res; 2008; 36():229-259. PubMed ID: 18230906
[TBL] [Abstract][Full Text] [Related]
11. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
[TBL] [Abstract][Full Text] [Related]
12. Obesity and cardiovascular physiology: impact of some pharmacological agents.
Chaput JP; Bérubé-Parent S; Tremblay A
Curr Vasc Pharmacol; 2005 Apr; 3(2):185-93. PubMed ID: 15853638
[TBL] [Abstract][Full Text] [Related]
13. [Drug treatment of obesity].
Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy for obesity.
Li M; Cheung BM
Br J Clin Pharmacol; 2009 Dec; 68(6):804-10. PubMed ID: 20002075
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of obesity.
Mancini MC; Halpern A
Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):377-89. PubMed ID: 16767304
[TBL] [Abstract][Full Text] [Related]
17. [Drug treatment of obesity].
Burniat W
Rev Med Brux; 2009; 30(2):124-6. PubMed ID: 19517912
[No Abstract] [Full Text] [Related]
18. The endocannabinoid system as a target for obesity treatment.
Aronne LJ; Pagotto U; Foster GD; Davis SN
Clin Cornerstone; 2008; 9(1):52-64; discussion 65-6. PubMed ID: 19046740
[TBL] [Abstract][Full Text] [Related]
19. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2004; 2003(3):CD004094. PubMed ID: 15266516
[TBL] [Abstract][Full Text] [Related]
20. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
